| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/12/1999 | US5859229 For inhibition of gene expression of human cyclooxygenase 2 by binding to specific untranslated regions of messenger rna; treatment of premature labor, preeclampsia, endometriosis, rheumatoid arthritis |
| 01/12/1999 | US5859219 Isolated nucleotide sequences used for detection of infection as primers for amplification and probes for hybridization; antiulcer agents; anticancer agents |
| 01/12/1999 | US5859201 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/12/1999 | US5859068 Administering under pressure a fluorocarbon liquid |
| 01/12/1999 | US5859067 Preparing bis(2-hydroxy-1-naphthyl)decane from the corresponding diacid; forming acid dichloride; treating with 2-naphthol; rearrangement; reduction; inhibits action of adenosine triphosphatase |
| 01/12/1999 | US5859066 Applying an effective amount a 1,4-naphthoquinone to the affected area of the skin |
| 01/12/1999 | US5859065 Treatment method for cancer |
| 01/12/1999 | US5859062 Guanylhydrazones and their use to treat inflammatory conditions |
| 01/12/1999 | US5859061 Matrix metalloproteinase inhibitors; treating diseases involving connective tissue degradation |
| 01/12/1999 | US5859060 Timed release tablet comprising naproxen and pseudoepherine |
| 01/12/1999 | US5859058 Administering ng-monomethyl-l-arginine |
| 01/12/1999 | US5859056 Synergistic |
| 01/12/1999 | US5859055 Administering one or both of linolenic and dihomo-g-linolenic acids |
| 01/12/1999 | US5859054 Leukotriene B4 derivatives, process for their production and their use as pharmaceutical agents |
| 01/12/1999 | US5859049 Calanolide and related antiviral compounds, compositions, and uses thereof |
| 01/12/1999 | US5859047 Antiarthritic agents, nervous system disorders |
| 01/12/1999 | US5859046 Biologically active oreido derivatives useful in the treatment of multiple sclerosis |
| 01/12/1999 | US5859045 Non-hydroscopic, good bioavailability, stability; administering to treat or prevent bone loss due to osteoporosis |
| 01/12/1999 | US5859044 Treating diabetes, hyperglycemia, obesity; increasing content of lean meat in animals |
| 01/12/1999 | US5859043 Method for maintaining kidney function during surgery or severe trauma under general anesthesia |
| 01/12/1999 | US5859042 Alopecia, acne, diseases of the prostate glands |
| 01/12/1999 | US5859041 Substituted imidazoles having cytokine inhibitory activity |
| 01/12/1999 | US5859039 Microbicidal triazolyl derivatives |
| 01/12/1999 | US5859038 Method for treatment of helicobacter pylori infections |
| 01/12/1999 | US5859037 Sulfonylurea-glitazone combinations for diabetes |
| 01/12/1999 | US5859036 Antiinflammatory agents, analgesics |
| 01/12/1999 | US5859034 Tri-substituted phenyl compounds which have useful pharmaceutical activity |
| 01/12/1999 | US5859032 Pyridine derivative, anti-ulcer drug, and antibacterial drug |
| 01/12/1999 | US5859031 Small molecule inhibitors of rotamase enzyme activity |
| 01/12/1999 | US5859030 Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria |
| 01/12/1999 | US5859029 Heterocyclic compounds method of preparing them and pharmeutical compositions in which they are present |
| 01/12/1999 | US5859028 Administering carotenoid synthesis inhibitory herbicide to treat mammalian species infected with protozoan parasite of phylum apicomplexa |
| 01/12/1999 | US5859027 Antimicrobial agent |
| 01/12/1999 | US5859025 Fluoroalkyl- and fluoroalkoxy-substituted heterocyclic bradykinin antagonists, process for their preparation, and their use |
| 01/12/1999 | US5859023 Formulations and compositions of poorly water soluble camptothecin derivatives |
| 01/12/1999 | US5859022 Suspensions in n-methyl-2-pyrrolidinone; for administration to a patient with cancer |
| 01/12/1999 | US5859021 Antiviral combinations |
| 01/12/1999 | US5859019 Methods for protecting against cardiac ischemia by administering adenosine A2a receptor antagonists |
| 01/12/1999 | US5859018 Antiarthritic agents; antitumor agents; cardiovascular disorders |
| 01/12/1999 | US5859017 Method for inhibiting mast cell and basophil activation |
| 01/12/1999 | US5859016 Treating dementia by administering acetylcholinesterase inhibitor |
| 01/12/1999 | US5859015 N-heterocyclic piperazinyl and H-heterocyclic piperazinonyl inhibitors of farnesyl-protein transferase |
| 01/12/1999 | US5859013 Method for inducing death of neoplastic cells using piperazine derivatives |
| 01/12/1999 | US5859012 Inhibitors of farnesyl-protein transferase |
| 01/12/1999 | US5859011 Dihydropyridine derivatives as bradykinin antagonist |
| 01/12/1999 | US5859010 Factor VII -binding reagent |
| 01/12/1999 | US5859009 Substituted spiroalkylamino and alkoxy heterocycles, processes for their preparation, and their use as pesticides and fungicides |
| 01/12/1999 | US5859008 Arylalkyl diazinones |
| 01/12/1999 | US5859007 Treatment of diabetes, obesity |
| 01/12/1999 | US5859006 Tetracyclic derivatives; process of preparation and use |
| 01/12/1999 | US5859005 Inhibitors of thrombin and factor xa |
| 01/12/1999 | US5859004 Use of heterocyclic compounds for the treatment of conditions caused by malfunctioning of the nicotinic cholinergic system |
| 01/12/1999 | US5859003 Antiallergens, antiasthmatics |
| 01/12/1999 | US5859002 HIV protease inhibitors |
| 01/12/1999 | US5859001 Neuroprotective effects of polycyclic phenolic compounds |
| 01/12/1999 | US5859000 Method for reducing mast cell mediated allergic reactions |
| 01/12/1999 | US5858999 Cosolvent parenteral formulation of tirilazad |
| 01/12/1999 | US5858998 Treatment of primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune cholangitis |
| 01/12/1999 | US5858995 Administering to humans and animals in the treatment of diseases caused by abnormal bone metabolism |
| 01/12/1999 | US5858994 Carbohydrate conjugates as inhibitors of cell adhesion |
| 01/12/1999 | US5858993 Administering to accelerate wound healing, stimulate hair growth |
| 01/12/1999 | US5858991 Administering a polysaccharide toxin to reduce scarring and to provide reduced vessel density at the site of the wound |
| 01/12/1999 | US5858986 Converting erythromycin a into its 9-oxime derivative; protecting 2' and 4? hydroxy groups; methylation; deprotecting and deoximating; treating with solvent; isolation; drying |
| 01/12/1999 | US5858985 Treating humans by inhaling into the bronchial passageways and lungs; device for inhalation; injectable solutions; side effect reduction |
| 01/12/1999 | US5858982 Cathepsin and methods and compositions for inhibition thereof |
| 01/12/1999 | US5858972 Cyclic peptide |
| 01/12/1999 | US5858964 Immunosuppressant |
| 01/12/1999 | US5858784 Aerosol transfecting agent |
| 01/12/1999 | US5858758 Human serine protease precursor |
| 01/12/1999 | US5858753 Purified, isolated polynucleotide coding catalytic subunit polypeptide similar to phosphatidylinisitol 3-kinase; anticancer agents; antiproliferative agents |
| 01/12/1999 | US5858740 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 01/12/1999 | US5858718 Pcr a |
| 01/12/1999 | US5858716 H2CAA71 polynucleotides |
| 01/12/1999 | US5858684 Contacting recombinant cell with test compound which is not verapamil or gallopamil, determining ability of compound to affect activities of inorganic ion receptor; determination of agonist and antagonist drugs |
| 01/12/1999 | US5858683 Determining presence of non-chromatin protein in biological sample (pap smears) by immunoassay or two-dimensional electrophoresis; accurate rapid diagnosis before metastasis occurs |
| 01/12/1999 | US5858662 Determining zygosity of individual by hybridization of nucleic acid probe or primer to sample; hemizygosity is indicator of impaired visuospatial constructive cognition |
| 01/12/1999 | US5858660 Parallel selex |
| 01/12/1999 | US5858643 Red blood cell composition containing vitamin E or derivatives thereof which exhibits reduced potassium ion leakage after a photoinactivation process |
| 01/12/1999 | US5858444 Blending fully hydrogenated oil consisting only of stearic acid and/or palmitic acid residues with another oil; low calorie foods and beverages |
| 01/12/1999 | US5858413 Contains at least one antacid active substance, sugar or sugar alcohol and water; liquid to semisolid consistency |
| 01/12/1999 | US5858408 Comprising a hydrophobic ointment base, an adhesive substance, an aluminum compound and a drug; remedy of oral diseases, such as periodontal disease |
| 01/12/1999 | US5858407 Method for administering tandospirone |
| 01/12/1999 | US5858405 Administering a bridged triphasic combination of progestins and estrogen; preferred progestins are trimegestone, dienogest and drospirenone |
| 01/12/1999 | US5858403 Picosulfate-containing preparation for colonic evacuation |
| 01/12/1999 | US5858402 Administering physiologically compatible transition metal chelate of dithiocarbamate-containing cyanide scavenger |
| 01/12/1999 | US5858400 Co-administering an agent having large liposomes that include phospholipids substantially free of sterol |
| 01/12/1999 | US5858397 Liposomal formulations of mitoxantrone |
| 01/12/1999 | US5858394 Agent for transdermal administration that contains gestodene esters |
| 01/12/1999 | US5858393 Transdermal patch comprising acrylic adhesive, muscarinic agonist; treating alzheimer*s disease, severe pain; reduced side effects |
| 01/12/1999 | US5858389 Squalene is an antiviral compound for treating hepatitis C virus carriers |
| 01/12/1999 | US5858388 Matrix of ethylene-vinyl acetate copolymer, hydromorphone embedded homogeneously in matrix and biocompatible, non-biodegradable polymer coating |
| 01/12/1999 | US5858376 Introducing into cell isolated protein derived from herpes simplex virus |
| 01/12/1999 | US5858373 Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them |
| 01/12/1999 | US5858371 Pharmaceutical composition for the control and treatment of anorectal and colonic diseases |
| 01/12/1999 | US5858365 Administering butyric acid and an amino acid, heptafluorobutyric acid, 3-chloropropionic acid, beta-chloro-l-alanine hydrochloride and isobutyramide for ulcers |
| 01/12/1999 | US5858345 In vivo polymerizable ophthalmic compositions |
| 01/12/1999 | US5858344 Oral administration form having acid active substances and a process for its production |
| 01/12/1999 | US5858334 Artificial tanning compositions comprising dihydroxyacetone |
| 01/12/1999 | US5858331 Prilocaine and hydrofluorocarbon aerosol preparations |
| 01/12/1999 | US5858326 Methods of increasing amyloid deposition |